Multimodal Theranostic Nanoformulations Permit Magnetic Resonance Bioimaging of Antiretroviral Drug Particle Tissue-Cell Biodistribution

RATIONALE: Long-acting slow effective release antiretroviral therapy (LASER ART) was developed to improve patient regimen adherence, prevent new infections, and facilitate drug delivery to human immunodeficiency virus cell and tissue reservoirs. In an effort to facilitate LASER ART development, “multimodal imaging theranostic nanoprobes” were created. These allow combined bioimaging, drug pharmacokinetics and tissue biodistribution tests in animal models. METHODS: Europium (Eu3+)- doped cobalt ferrite (CF) dolutegravir (DTG)- loaded (EuCF-DTG) nanoparticles were synthesized then fully characterized based on their size, shape and stability. These were then used as platforms for nanoformulated drug biodistribution. RESULTS: Folic acid (FA) decoration of EuCF-DTG (FA-EuCF-DTG) nanoparticles facilitated macrophage targeting and sped drug entry across cell barriers. Macrophage uptake was higher for FA-EuCF-DTG than EuCF-DTG nanoparticles with relaxivities of r2 = 546 mM-1s-1 and r2 = 564 mM-1s-1 in saline, and r2 = 850 mM-1s-1 and r2 = 876 mM-1s-1 in cells, respectively. The values were ten or more times higher than what was observed for ultrasmall superparamagnetic iron oxide particles (r2 = 31.15 mM-1s-1 in saline) using identical iron concentrations. Drug particles were detected in macrophage Rab compartments by dual fluorescence labeling. Replicate particles elicited sustained antiretroviral responses. After parenteral injection of FA-EuCF-DTG and EuCF-DTG into rats and rhesus macaques, drug, iron and cobalt levels, measured by LC-MS/MS, magnetic resonance imaging, and ICP-MS were coordinate. CONCLUSION: We posit that these theranostic nanoprobes can assess LASER ART drug delivery and be used as part of a precision nanomedicine therapeutic strategy.

[1]  B. Brunekreef,et al.  Lipid-coated polymeric nanoparticles for cancer drug delivery , 2018 .

[2]  A. Qin,et al.  Targeting Osteocytes to Attenuate Early Breast Cancer Bone Metastasis by Theranostic Upconversion Nanoparticles with Responsive Plumbagin Release. , 2017, ACS nano.

[3]  P. Ziprin,et al.  Stabilization and Sustained Release of HIV Inhibitors by Encapsulation in Silk Fibroin Disks. , 2017, ACS biomaterials science & engineering.

[4]  Miles A. Miller,et al.  Radiation therapy primes tumors for nanotherapeutic delivery via macrophage-mediated vascular bursts , 2017, Science Translational Medicine.

[5]  Z. Qian,et al.  Long-Acting Release Formulation of Exendin-4 Based on Biomimetic Mineralization for Type 2 Diabetes Therapy. , 2017, ACS nano.

[6]  A. Cingolani,et al.  Long-acting agents for HIV infection: biological aspects, role in treatment and prevention, and patient's perspective. , 2017, The new microbiologica.

[7]  B. Taiwo,et al.  Long-Acting Antiretrovirals: Where Are We now? , 2017, Current HIV/AIDS Reports.

[8]  H. Gendelman,et al.  A mature macrophage is a principal HIV-1 cellular reservoir in humanized mice after treatment with long acting antiretroviral therapy , 2017, Retrovirology.

[9]  H. Gendelman,et al.  Autophagy facilitates macrophage depots of sustained-release nanoformulated antiretroviral drugs , 2017, The Journal of clinical investigation.

[10]  H. Gendelman,et al.  Long-acting slow effective release antiretroviral therapy , 2017, Expert opinion on drug delivery.

[11]  Howard E Gendelman,et al.  Development of europium doped core-shell silica cobalt ferrite functionalized nanoparticles for magnetic resonance imaging. , 2017, Acta biomaterialia.

[12]  J. Champion,et al.  Tunable particles alter macrophage uptake based on combinatorial effects of physical properties , 2017, Bioengineering & translational medicine.

[13]  B. Alman,et al.  Phenotype Determines Nanoparticle Uptake by Human Macrophages from Liver and Blood. , 2017, ACS nano.

[14]  D. Danino,et al.  Amphiphilic Nanoparticle-in-Nanoparticle Drug Delivery Systems Exhibiting Cross-Linked Inorganic Rate-Controlling Domains , 2017 .

[15]  S. Gambhir,et al.  Nanomaterials for In Vivo Imaging. , 2017, Chemical reviews.

[16]  H. Gendelman,et al.  Creation of a Long-Acting Nanoformulated 2′,3′-Dideoxy-3′-Thiacytidine , 2016, Journal of acquired immune deficiency syndromes.

[17]  Morteza Mahmoudi,et al.  Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues. , 2016, Nature nanotechnology.

[18]  Ameya R. Kirtane,et al.  Past, Present, and Future Drug Delivery Systems for Antiretrovirals. , 2016, Journal of pharmaceutical sciences.

[19]  H. Gendelman,et al.  Development and characterization of a long-acting nanoformulated abacavir prodrug. , 2016, Nanomedicine.

[20]  E. Vicenzi,et al.  Immuno-Pharmacological Targeting of Virus-Containing Compartments in HIV-1-Infected Macrophages. , 2016, Trends in microbiology.

[21]  S. Naseem,et al.  Magnetic Properties of Polyvinyl Alcohol and Doxorubicine Loaded Iron Oxide Nanoparticles for Anticancer Drug Delivery Applications , 2016, PloS one.

[22]  L. Dobrucki,et al.  Efficient Targeting of Adipose Tissue Macrophages in Obesity with Polysaccharide Nanocarriers. , 2016, ACS nano.

[23]  R. Reid,et al.  Subcutaneously Administered Self-Cleaving Hydrogel-Octreotide Conjugates Provide Very Long-Acting Octreotide. , 2016, Bioconjugate chemistry.

[24]  W. Zamboni,et al.  Design, Synthesis, and Characterization of Folate-Targeted Platinum-Loaded Theranostic Nanoemulsions for Therapy and Imaging of Ovarian Cancer. , 2016, Molecular pharmaceutics.

[25]  Robert Langer,et al.  Emerging Frontiers in Drug Delivery , 2016 .

[26]  R. Landovitz,et al.  The promise and pitfalls of long-acting injectable agents for HIV prevention , 2016, Current opinion in HIV and AIDS.

[27]  L. Thoma,et al.  Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[28]  Shih-Feng Chou,et al.  Current strategies for sustaining drug release from electrospun nanofibers. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[29]  Jan Grimm,et al.  Multifunctional MRI/PET Nanobeacons Derived from the in Situ Self-Assembly of Translational Polymers and Clinical Cargo through Coalescent Intermolecular Forces. , 2015, Nano letters.

[30]  J. Eron,et al.  Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trial. , 2015, The Lancet. Infectious diseases.

[31]  Darren L. Smith,et al.  Augmented Inhibition of CYP3A4 in Human Primary Hepatocytes by Ritonavir Solid Drug Nanoparticles. , 2015, Molecular pharmaceutics.

[32]  B. Forbes,et al.  In vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug delivery , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[33]  W. Heneine,et al.  Cabotegravir long-acting for HIV-1 prevention , 2015, Current opinion in HIV and AIDS.

[34]  H. Gendelman,et al.  Magnetic resonance imaging of folic acid-coated magnetite nanoparticles reflects tissue biodistribution of long-acting antiretroviral therapy , 2015, International journal of nanomedicine.

[35]  L. Salassa,et al.  An Iron Oxide Nanocarrier Loaded with a Pt(IV) Prodrug and Immunostimulatory dsRNA for Combining Complementary Cancer Killing Effects , 2015, Advanced healthcare materials.

[36]  D. Dimitrov,et al.  Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations. , 2015, Biomaterials.

[37]  W. Heneine,et al.  The long-acting integrase inhibitor GSK744 protects macaques from repeated intravaginal SHIV challenge , 2015, Science Translational Medicine.

[38]  L. Gleaves,et al.  Molecular imaging of folate receptor β-positive macrophages during acute lung inflammation. , 2014, American journal of respiratory cell and molecular biology.

[39]  H. Gendelman,et al.  Pharmacokinetics, Biodistribution, and Toxicity of Folic Acid-Coated Antiretroviral Nanoformulations , 2014, Antimicrobial Agents and Chemotherapy.

[40]  Sanjay Mathur,et al.  Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[41]  Beata J. Wysocki,et al.  Endosomal Trafficking of Nanoformulated Antiretroviral Therapy Facilitates Drug Particle Carriage and HIV Clearance , 2014, Journal of Virology.

[42]  J. Berman,et al.  Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disorders. , 2014, Current HIV research.

[43]  V. Gladyshev,et al.  Genome-Wide RNAi Ionomics Screen Reveals New Genes and Regulation of Human Trace Element Metabolism , 2014, Nature Communications.

[44]  R. Weissleder,et al.  Imaging macrophages with nanoparticles. , 2014, Nature materials.

[45]  H. Bajaj,et al.  Evaluation of Montmorillonite/Poly (L-Lactide) microcomposite spheres as ambidextrous reservoirs for controlled release of Capecitabine (Xeloda) and assessment of cell cytotoxic and oxidative stress markers , 2014 .

[46]  Efstathios Karathanasis,et al.  Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles. , 2014, Nanomedicine.

[47]  H. Shokrollahi,et al.  Magnetic and structural properties of RE doped Co-ferrite (REåNd, Eu, and Gd) nano-particles synthesized by co-precipitation , 2013 .

[48]  H. Gendelman,et al.  Macrophage folate receptor-targeted antiretroviral therapy facilitates drug entry, retention, antiretroviral activities and biodistribution for reduction of human immunodeficiency virus infections. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[49]  W. Spreen,et al.  Long-acting injectable antiretrovirals for HIV treatment and prevention , 2013, Current opinion in HIV and AIDS.

[50]  P. Cicuta,et al.  Phagocytosis dynamics depends on target shape. , 2013, Biophysical journal.

[51]  Matthias Nahrendorf,et al.  Monocytes and macrophages as nanomedicinal targets for improved diagnosis and treatment of disease , 2013, Expert review of molecular diagnostics.

[52]  S. Heximer,et al.  Rab Family Proteins Regulate the Endosomal Trafficking and Function of RGS4* , 2013, The Journal of Biological Chemistry.

[53]  L. B. Thomsen,et al.  Development of a Novel Lipophilic, Magnetic Nanoparticle for in Vivo Drug Delivery , 2013, Pharmaceutics.

[54]  Taeghwan Hyeon,et al.  Theranostic Probe Based on Lanthanide‐Doped Nanoparticles for Simultaneous In Vivo Dual‐Modal Imaging and Photodynamic Therapy , 2012, Advanced materials.

[55]  Hong Ding,et al.  Image Guided Biodistribution and Pharmacokinetic Studies of Theranostics , 2012, Theranostics.

[56]  M. Schindler,et al.  Macrophages and their relevance in Human Immunodeficiency Virus Type I infection , 2012, Retrovirology.

[57]  Jing Yao,et al.  Preparation of Irinotecan-Loaded Folate-Targeted Liposome for Tumor Targeting Delivery and Its Antitumor Activity , 2012, AAPS PharmSciTech.

[58]  G. Guebitz,et al.  Folic acid-functionalized human serum albumin nanocapsules for targeted drug delivery to chronically activated macrophages. , 2012, International journal of pharmaceutics.

[59]  Andrew Emili,et al.  Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. , 2012, Journal of the American Chemical Society.

[60]  M. Marsh,et al.  Rab7A Is Required for Efficient Production of Infectious HIV-1 , 2011, PLoS pathogens.

[61]  Thommey P. Thomas,et al.  Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis. , 2011, Arthritis and rheumatism.

[62]  A. D. Bain,et al.  Exact solution of the CPMG pulse sequence with phase variation down the echo train: application to R₂ measurements. , 2011, Journal of magnetic resonance.

[63]  P. Saberi,et al.  Improving adherence and clinical outcomes through an HIV pharmacist's interventions , 2010, AIDS care.

[64]  H. Bajaj,et al.  Layered bionanocomposites as carrier for procainamide. , 2010, International journal of pharmaceutics.

[65]  Karen Chang,et al.  Formulation of novel lipid-coated magnetic nanoparticles as the probe for in vivo imaging , 2009, Journal of Biomedical Science.

[66]  Philip S Low,et al.  Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. , 2008, Accounts of chemical research.

[67]  Robert J. Lee,et al.  Targeted drug delivery via folate receptors. , 2008, Expert opinion on drug delivery.

[68]  G. Gras,et al.  Macrophage activation and human immunodeficiency virus infection: HIV replication directs macrophages towards a pro-inflammatory phenotype while previous activation modulates macrophage susceptibility to infection and viral production. , 2006, Virology.

[69]  Shiladitya Sengupta,et al.  Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system , 2005, Nature.

[70]  Philip S Low,et al.  Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis. , 2004, Advanced drug delivery reviews.

[71]  H. Gendelman,et al.  Inhibition of human immunodeficiency virus infection in monocytes by monoclonal antibodies against leukocyte adhesion molecules. , 1991, Immunology letters.

[72]  D. Burke,et al.  Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes , 1988, The Journal of experimental medicine.